By enhancing endoplasmic reticulum folding capacity, AGR2 allows pre-cancerous cells to accommodate increased protein demand both before and after oncogenic mutations such as that of Kras, ultimately leading to pancreatic cancer progression [48]. Here, KRAS is linked to familial pancreatic carcinoma.